Corticosteroids confirmation

E. Therapeutic response The safety and efficacy of Simulect, when added to a standard immunosuppressive regimen comprised of cyclosporine and corticosteroids, were assessed in two placebo-controlled trials. The primary end point in both studies was the incidence of death, graft loss, or an episode of acute rejection during the first 6 months post-transplantation. Patients receiving Simulect experienced a significantly lower incidence of biopsy-confirmed rejection episodes at both 6 and 12 months after transplantation, but there was no difference in the rate of delayed graft function, patient survival, or graft survival between Simulect-treated patients and placebo-treated patients in either study. 

How corticosteroids prevent vomiting is unclear, but many studies have confirmed the effectiveness of a single dose of dexamethasone against a variety of anticancer agents. A randomized trial found... 

A 47-year-old mildly obese woman began a weight-reduction program that included anorectic therapy with phentermine and phendimetrazine. She had normal renal function at the start of therapy. After 3 weeks of treatment she fell ill and discontinued treatment. She was subsequently found to have leukocyturia, a rash on her face and chest, and a rise in serum creatinine from 67 to 175 pmol/l (0.8-2.1 mg/dl). Renal biopsy confirmed the diagnosis of acute interstitial nephritis. She was treated with corticosteroids and her renal function returned to normal. 

A 53-year-old white woman with liver cirrhosis took vancomycin (1 g bd) for sepsis due to methicillin-resistant S. aureus and a catheter-associated infection due to Enterococcus faecalis, developed oral and vaginal mucositis and conjunctivitis followed by a macu-lopapular rash (69). The diagnosis was confirmed by skin biopsy. Vancomycin was replaced by teicoplanin and corticosteroids the symptoms disappeared within 7 days. 

Tang et al. [58] reported the analysis of corticosteroids in eqnine urine after enzymatic hydrolysis, liquid-liquid extraction (LLE) with ethyl acetate, and LC-MS-MS in positive-ion APCl mode. Hydrocortisone, deoxycorticosterone, and 21 synthetic corticosteroids can be analysed at 5 pg/1 level in urine within 10 min. As an example, the confirmation of deoxycortone in a urine sample is demonstrated in Figure 13.8. 

For the analysis of corticosteroids, some of the methods described are the determination of corticosteroids in feed and mine [77], the analysis of dexamethasone and betamethasone in bovine hver [78], a multiresidne method for the quantification and confirmation of five corticosteroids in urine [79], and the analysis of seven corticosteroids in bovine mine [80], The LOQ for corticosteroids in urine are generally around 1 pg/1. 

M.J. O Keeffe, S. Martin, L. Regan, Validation of a multiresidue LC-MS-MS method for the quantitation and confirmation of corticosteroid residues in urine, according to the proposed SANCO 1085 criteria for banned substances. Anal. Chim. Acta, 483 (2003)341. 

The possible modes of action of indomethacin remain to be a subject of active interest. As a reference compound it has been found to be active in most of the in vitro and in vivo assays mentioned above. While none of these can be considered as the primary mode of action, certainly several are contributory. An earlier report of kallikrein inhibition was not confirmed.The suggestion37 that the antiinflammatory activity of indomethacin may be due to the displacement of tissue-bound corticosteroid has also been disputed. 3 The distribution cind metabolism of indomethacin in various species have been reported in detail39, and a number of long-term clinical studies have been published. 3... 

Since the two meta-analyses in 1995, five prospective, randomized, controlled trials of low-dose corticosteroids in vasopressor-dependent septic shock patients (n = 505) have been published. " These smdies used moderate physiologic doses (200 to 300 mg/day) of hydrocortisone. A meta-analysis of these studies showed that steroid therapy was associated with an overall improvement in survival rate (odds ratio [OR] 1.52, 95% confidence interval [Cl] 1.03-2.27 p =. 036) and shock reversal (OR 4.79, 95% Cl 2.07-11.11 p =. 001). These effects were beneficial in both responders and nonresponders to corticotrophin stimulation testing (p =. 63 and p =. 75, respectively). These smdies also showed that low-dose corticosteroid administration improves hemodynamics and reduces the duration of vasopressor support. " All these studies differ from earlier smdies in that steroids were admimstered later in septic shock (23 hours versus less than 2 hours p =. 02). In these studies, steroids were administered longer (6 days versus 1 day p =. 004), doses were tapered, lower doses were used (hydrocortisone eqmvalents 1209 mg versus 23,975 mg p =. 01), aU patients received high doses of catecholamine vasopressors, and control groups had higher mortality rates (mean 57% versus 34% p =. 03). Since only one of the five studies showed a mortality benefit of low-dose steroids in septic shock, further research is required to confirm this finding. ... 

FSGS. These favorable results have, however, not been confirmed in studies using a larger number of patients. Thus their role in the overall scheme of therapy remains to be defined. For patients with more severe disease, corticosteroids with or without immunosuppressive agents should be considered. Treatment should not be continued for more than 3 to 4 months unless the patient experiences a remission. In this case, therapy may be continued for 12 to 24 mouths to maiutaiu the therapeutic respouse. 

Remission of proteinuria, whether spontaneously or treatment related, may confer a good prognosis. Corticosteroids alone were ineffective in increasing the remission rate of proteinuria in all controlled trials and in preventing progression in all but one study. The result of a meta-analysis also confirmed the lack of efficacy of steroids alone. 

---